There have been 50 recent insider transactions recorded for Mirum Pharmaceuticals, Inc. (MIRM), including 8 buys and 41 sells. Total insider buying was valued at $15.26M and total insider selling at $20.05M.
Notable insiders with recent activity include Bjerkholt Eric, Ramasastry Saira, Peetz Christopher. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.
Insider Transactions — MIRM
| Date |
Name |
Role |
Transaction |
Shares |
Avg. Price |
Value |
Shares Owned |
| 2026-03-16 |
Bjerkholt Eric |
Chief Financial Officer |
Informative Sell |
7,287 |
$91.98 |
$670.24K |
49,788 |
| 2026-03-16 |
Ramasastry Saira |
Director |
Informative Sell |
2,000 |
$90.76 |
$181.52K |
- |
| 2026-03-16 |
Peetz Christopher |
Chief Executive Officer |
Informative Sell |
40,985 |
$91.98 |
$3.77M |
194,309 |
| 2026-03-16 |
Radovich Peter |
President and COO |
Informative Sell |
16,515 |
$91.98 |
$1.52M |
40,272 |
| 2026-03-16 |
Quan Joanne |
Chief Medical Officer |
Informative Sell |
7,287 |
$91.98 |
$670.24K |
18,864 |
| 2026-03-16 |
Howe Jolanda |
SVP, Global Controller |
Informative Sell |
4,732 |
$91.98 |
$435.24K |
8,429 |
| 2026-03-15 |
Bjerkholt Eric |
Chief Financial Officer |
Option Exercise (Sell) |
13,334 |
- |
- |
6,666 |
| 2026-03-15 |
Peetz Christopher |
Chief Executive Officer |
Option Exercise (Sell) |
25,000 |
- |
- |
- |
| 2026-03-15 |
Radovich Peter |
President and COO |
Option Exercise (Sell) |
7,220 |
- |
- |
- |
| 2026-03-15 |
Quan Joanne |
Chief Medical Officer |
Option Exercise (Sell) |
13,334 |
- |
- |
6,666 |
| 2026-03-15 |
Howe Jolanda |
SVP, Global Controller |
Option Exercise (Sell) |
2,658 |
- |
- |
- |
| 2026-03-06 |
Radovich Peter |
President and COO |
Option Exercise |
5,912 |
$15.87 |
$93.82K |
26,567 |
| 2026-02-13 |
Ramasastry Saira |
Director |
Informative Sell |
2,000 |
$102.09 |
$204.18K |
- |
| 2026-02-02 |
Peetz Christopher |
Chief Executive Officer |
Informative Sell |
9,108 |
$103.30 |
$940.88K |
160,294 |
| 2026-02-02 |
Radovich Peter |
President and COO |
Informative Sell |
2,631 |
$103.30 |
$271.79K |
20,655 |
| 2026-02-02 |
Howe Jolanda |
SVP, Global Controller |
Informative Sell |
968 |
$103.30 |
$100K |
4,503 |
| 2026-01-31 |
Howe Jolanda |
SVP, Global Controller |
Option Exercise (Sell) |
1,771 |
- |
- |
- |
| 2026-01-28 |
Bjerkholt Eric |
Chief Financial Officer |
RSU Award |
11,760 |
- |
- |
11,760 |
| 2026-01-28 |
Peetz Christopher |
Chief Executive Officer |
RSU Award |
43,500 |
- |
- |
43,500 |
| 2026-01-28 |
Radovich Peter |
President and COO |
RSU Award |
16,280 |
- |
- |
16,280 |
| 2026-01-28 |
Quan Joanne |
Chief Medical Officer |
RSU Award |
11,760 |
- |
- |
11,760 |
| 2026-01-28 |
Howe Jolanda |
SVP, Global Controller |
RSU Award |
4,970 |
- |
- |
4,970 |
| 2026-01-26 |
Bjerkholt Eric |
Chief Financial Officer |
Informative Sell |
1,053 |
$96.19 |
$101.29K |
43,741 |
| 2026-01-26 |
Peetz Christopher |
Chief Executive Officer |
Informative Sell |
6,831 |
$96.19 |
$657.09K |
169,402 |
| 2026-01-26 |
Radovich Peter |
President and COO |
Informative Sell |
3,143 |
$96.19 |
$302.33K |
23,286 |
| 2026-01-26 |
Howe Jolanda |
SVP, Global Controller |
Informative Sell |
842 |
$96.19 |
$80.99K |
3,700 |
| 2026-01-23 |
Bjerkholt Eric |
Chief Financial Officer |
Option Exercise (Sell) |
2,667 |
- |
- |
2,666 |
| 2026-01-23 |
Heron Patrick J |
Director |
Other (Buy) |
159,277 |
$94.29 |
$15.02M |
327,585 |
| 2026-01-23 |
Peetz Christopher |
Chief Executive Officer |
Option Exercise (Sell) |
12,500 |
- |
- |
12,500 |
| 2026-01-23 |
Radovich Peter |
President and COO |
Option Exercise (Sell) |
5,750 |
- |
- |
5,750 |
| 2026-01-23 |
Howe Jolanda |
SVP, Global Controller |
Option Exercise (Sell) |
1,500 |
- |
- |
1,500 |
| 2026-01-22 |
Bjerkholt Eric |
Chief Financial Officer |
Informative Sell |
1,421 |
$93.33 |
$132.62K |
42,127 |
| 2026-01-22 |
Peetz Christopher |
Chief Executive Officer |
Informative Sell |
7,098 |
$93.33 |
$662.42K |
163,733 |
| 2026-01-22 |
Radovich Peter |
President and COO |
Informative Sell |
2,382 |
$93.33 |
$222.3K |
20,679 |
| 2026-01-22 |
Quan Joanne |
Chief Medical Officer |
Informative Sell |
1,822 |
$93.33 |
$170.04K |
12,817 |
| 2026-01-22 |
Howe Jolanda |
SVP, Global Controller |
Informative Sell |
926 |
$93.33 |
$86.42K |
3,042 |
| 2026-01-21 |
Bjerkholt Eric |
Chief Financial Officer |
Option Exercise (Sell) |
3,334 |
- |
- |
6,666 |
| 2026-01-21 |
Peetz Christopher |
Chief Executive Officer |
Option Exercise (Sell) |
12,797 |
- |
- |
25,593 |
| 2026-01-21 |
Radovich Peter |
President and COO |
Option Exercise (Sell) |
4,167 |
- |
- |
8,333 |
| 2026-01-21 |
Quan Joanne |
Chief Medical Officer |
Option Exercise (Sell) |
3,334 |
- |
- |
6,666 |
| 2026-01-21 |
Howe Jolanda |
SVP, Global Controller |
Option Exercise (Sell) |
1,542 |
- |
- |
3,083 |
| 2026-01-20 |
Quan Joanne |
Chief Medical Officer |
Informative Sell |
6,911 |
$90.27 |
$623.85K |
11,305 |
| 2026-01-16 |
Quan Joanne |
Chief Medical Officer |
Option Exercise (Sell) |
12,500 |
- |
- |
12,500 |
| 2026-01-15 |
Ramasastry Saira |
Director |
Informative Sell |
2,000 |
$90.99 |
$181.98K |
- |
| 2025-12-31 |
Peetz Christopher |
Chief Executive Officer |
Gift (Given) |
21,070 |
- |
- |
187,500 |
| 2025-12-22 |
Ramasastry Saira |
Director |
Informative Sell |
5,000 |
$80.00 |
$400K |
- |
| 2025-12-19 |
Grey Michael G |
Director |
Informative Sell |
50,000 |
$78.00 |
$3.9M |
- |
| 2025-12-18 |
Ramasastry Saira |
Director |
Informative Sell |
1,000 |
$70.00 |
$70K |
- |
| 2025-12-01 |
Grey Michael G |
Director |
Informative Sell |
50,000 |
$74.00 |
$3.7M |
- |
| 2025-11-21 |
Grey Michael G |
Director |
Option Exercise |
50,000 |
$2.94 |
$146.8K |
50,000 |
■ Informative Buy/Sell — open market transaction (most significant)
■ Uninformative Buy — award, option exercise, conversion
■ Uninformative Sell — tax withholding, award vest sale
■ Neutral — gift, trust, expiry
